Peter Wijngaard, Director at Hepion Pharmaceuticals, Inc. (HEPA), bought 5,000 shares at $3.05 ($15K) on 2023-11-27, disclosed to the SEC on 2023-11-28.
Open-market purchase of $15k HEPA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.09 | 2,500 | $8K | 50.3% |
| 2 | $3.05 | 2,500 | $8K | 49.7% |
| Total | $3.07 avg | 5,000 | $15K | 100% |
| Filing → |
| HEPA | BUY | 2020-12-21 | $38K | — | Filing → |